IPATH Scientific Reports

​Clinical Infectious Diseases |​ ​​June 3, 2023

Therapeutic Potential of Intravenous Phage as Standalone Therapy for Recurrent Drug-Resistant Urinary Tract Infections​

Antimicrobial Agents and Chemotherapy | March 28, 2023

Development of Host Immune Response to Bacteriophage in a Lung Transplant Recipient on Adjunctive Phage Therapy for a Multidrug-Resistant Pneumonia​

Journal of Infectious Diseases | February 1, 2023

Phage Therapy of Mycobacterium Infections: Compassionate Use of Phages in 20 Patients With Drug-Resistant Mycobacterial Disease​

Clinical Infectious Diseases | January 6, 2023

Bacteriophage treatment of disseminated cutaneous Mycobacterium chelonae infection​

Nature Communications | ​​May 3, 2022 

Comparative genomics of Acinetobacter baumannii and therapeutic bacteriophages from a patient undergoing phage therapy​

Nature Communications | June 30, 2022

Bacteriophage Rescue Therapy of a Vancomycin-Resistant Enterococcus faecium Infection in a One-Year-Old Child following a Third Liver Transplantation​

Viruses | September 7, 2021

Successful Treatment of Staphylococcus aureus Prosthetic Joint Infection with Bacteriophage Therapy​

Viruses | June 21, 2021

Assessment of the microbiome during bacteriophage therapy in combination with systemic antibiotics to treat a case of staphylococcal device infection​

Microbiome | April 14, 2021

Phage Therapy Related Microbial Succession Associated with Successful Clinical Outcome for a Recurrent Urinary Tract Infection​

Viruses | October 12, 2021

Lessons Learned from First Ten Consecutive Cases of Intravenous Bacteriophage Therapy to Treat Multidrug Resistant Bacterial Infections at a Single Center in the US​

Open Forum Infectious Diseases | August 27, 2020

Novel bacteriophage therapy for treatment of left ventricular assist device infection​

The Journal of Heart and Lung Transplantation | April 2019

Successful adjunctive use of bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa infection in a cystic fibrosis patient​

Infection | August 2019

Early clinical experience of bacteriophage therapy in three lung transplant recipients​

American Journal of Transplantation | September, 2019

Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus​

Nature Medicine |​ May 8, 2019

Successful treatment of antibiotic resistant poly-microbial bone infection with bacteriophages and antibiotics combination​

Clinical Infectious Diseases |​ November 13, 2019

Phage Therapy for a Multidrug-Resistant Acinetobacter baumannii Craniectomy Site Infection​

Open Forum Infectious Diseases |​ March 23, 2018

Development and Use of Personalized Bacteriophage-Based Therapeutic Cocktails To Treat a Patient with a Disseminated Resistant Acinetobacter baumannii Infection​

Antimicrobial Agents and Chemotherapy |​ September 22, 2​017

​ Exploring bacteriophage therapy for drug-resistant bacterial infections.​

Topics in Antiviral Medicine |​ March 31, 2023​

Phage therapy: From biological mechanisms to future directions​

Role of bacteriophage therapy for resistant infections in transplant recipients​

Current Opinion in Organ Transplantation |​ December 1, 2022

Phage Therapy for Antibiotic-Resistant Bacterial Infections​

Annual Review of Medicine | January 27, 2022

Considerations for the Use of Phage Therapy in Clinical Practice​

Antimicrobial Agents and Chemotherapy | March 15, 2022

Phage Therapy: Primer and Role in the Treatment of MDROs​

Current Infectious Disease Reports | November 13, 2020

Bacteriophage therapy as a treatment option for transplant infections​

Current Opinion in Infectious Diseases |​ August 2020

Treat phage like living antibiotics​

Nature Microbiology |​ February 26, 2020

What's Old Is New Again: Bacteriophage Therapy in the 21st Century

Antimicrobial Agents and Chemotherapy |​ December 20, 2019

Stronger together? Perspectives on phage-antibiotic synergy in clinical applications of phage therapy​

Current Opinion in Microbiology |​ October 2019​

​ Isolation of a Peptide That Binds to Pseudomonas aeruginosa Lytic Bacteriophage​​

ACS Omega | October 12, 2022

Increased Innate Immune Susceptibility in Hyperpigmented Bacteriophage-Resistant Mutants of Pseudomonas aeruginosa​

​Phage Cocktails Constrain the Growth of Enterococcus​​

Animal Models of Phage Therapy​

Clinical Phage Microbiology: a suggested framework and recommendations for the in-vitro matching steps of phage therapy​​

The Lancet, Microbe |​ ​October, 2021​

​ Jumbo phages are active against extensively-drug-resistant eyedrop-associated Pseudomonas aeruginosa infections​​​